Doctors Aren’t Disclosing Drug Company Ties
Recently, the New York Times revealed that one of the world’s top cancer specialists had quietly received millions of dollars from drug and other companies and had failed to disclose the payments in many of his high-profile medical journal articles.
A recent Australian study has uncovered a similar problem here, finding that at least one out of five doctors who write influential clinical guidelines, have an undisclosed financial relationship with a drug company.
So how does this impact the sort of care you receive from a doctor, and which drugs you’re prescribed?
The Daily’s Victor Petrovic discussed this with Professor Lisa Bero, a researcher in evidence-based health care from the Sydney School of Pharmacy, University of Sydney.
